Since the immune checkpoint pathways were largely normal in NPmut mice (data not shown), we believe that the reduced T cell compartment in NPmut-AML recipients did not result from a suppressive immune microenvironment, as we had previously described in NrasG12D/+Asxl1–/– mice (10). The gene discussed is ASXL1; the disease is acute myeloid leukemia.